{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:47:19Z","timestamp":1784076439277,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.urolonc.2016.07.004","type":"journal-article","created":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T02:25:15Z","timestamp":1474511115000},"page":"530.e9-530.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prostate magnetic resonance imaging findings in patients treated for testosterone deficiency while on active surveillance for low-risk prostate cancer"],"prefix":"10.1016","volume":"34","author":[{"given":"Takeshi","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnan","family":"Rahul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikazu","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Benfante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Mulhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedvig","family":"Hricak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Eastham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebert Alberto","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2016.07.004_bib1","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1111\/jsm.12952","article-title":"The International Society for Sexual Medicine\u2019s process of care for the assessment and management of testosterone deficiency in adult men","volume":"12","author":"Dean","year":"2015","journal-title":"J Sex Med"},{"key":"10.1016\/j.urolonc.2016.07.004_bib2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","article-title":"Longitudinal effects of aging on serum total and free testosterone levels in healthy men","volume":"86","author":"Harman","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.urolonc.2016.07.004_bib3","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/jama.296.19.2351","article-title":"Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial","volume":"296","author":"Marks","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.urolonc.2016.07.004_bib4","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.juro.2015.01.089","article-title":"Active surveillance is an appropriate management strategy for a proportion of men diagnosed with prostate cancer by prostate specific antigen testing","volume":"194","author":"Overholser","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.07.004_bib5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2013.09.046","article-title":"EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013","volume":"65","author":"Heidenreich","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.07.004_bib6","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1200\/JCO.2015.62.5764","article-title":"Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer","volume":"33","author":"Tosoian","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2016.07.004_bib7","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/1097-0142(196711)20:11<1871::AID-CNCR2820201112>3.0.CO;2-D","article-title":"Response of men with advanced prostatic carcinoma to exogenous administration of testosterone","volume":"20","author":"Prout","year":"1967","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2016.07.004_bib8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0022-5347(17)54531-0","article-title":"The response of metastatic adenocarcinoma of the prostate to exogenous testosterone","volume":"126","author":"Fowler","year":"1981","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.07.004_bib9","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.juro.2010.11.084","article-title":"Testosterone therapy in men with untreated prostate cancer","volume":"185","author":"Morgentaler","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.07.004_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/1008-682X.160270","article-title":"Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results","volume":"18","author":"Kacker","year":"2016","journal-title":"Asian J Androl"},{"key":"10.1016\/j.urolonc.2016.07.004_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.juro.2016.04.069","article-title":"Testosterone therapy in patients with treated and untreated prostate cancer: impact on oncologic outcomes","author":"Ory","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.07.004_bib12","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1111\/jsm.12657","article-title":"Factors influencing prostate-specific antigen response among men treated with testosterone therapy for 6 months","volume":"11","author":"Morgentaler","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.urolonc.2016.07.004_bib13","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.juro.2012.07.024","article-title":"Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer","volume":"188","author":"Vargas","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.07.004_bib14","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.eururo.2015.10.010","article-title":"Nine-year follow-up for a study of diffusion-weighted magnetic resonance imaging in a prospective prostate cancer active surveillance cohort","volume":"69","author":"Henderson","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.07.004_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.urolonc.2015.01.023","article-title":"Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance","volume":"33","author":"Walton Diaz","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2016.07.004_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1259\/bjr\/14556365","article-title":"Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance","volume":"84","author":"Morgan","year":"2011","journal-title":"Br J Radiol"},{"key":"10.1016\/j.urolonc.2016.07.004_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/RLI.0000000000000008","article-title":"Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study","volume":"49","author":"Hoeks","year":"2014","journal-title":"Invest Radiol"},{"key":"10.1016\/j.urolonc.2016.07.004_bib18","unstructured":"American College of Radiology. MR prostate imaging reporting and data system version 2.0. Available from: http:\/\/www.acr.org\/Quality-Safety\/Resources\/PIRADS\/; [accessed April 2015]."},{"key":"10.1016\/j.urolonc.2016.07.004_bib19","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1007\/s00330-015-4015-6","article-title":"Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference","volume":"26","author":"Vargas","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.urolonc.2016.07.004_bib20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ucl.2007.08.007","article-title":"The role of testosterone replacement therapy following radical prostatectomy","volume":"34","author":"Khera","year":"2007","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2016.07.004_bib21","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.juro.2006.06.003","article-title":"The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men?","volume":"176","author":"Kaplan","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.07.004_bib22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2164\/jandrol.108.007245","article-title":"The dark side of testosterone deficiency III: cardiovascular disease","volume":"30","author":"Traish","year":"2009","journal-title":"J Androl"},{"key":"10.1016\/j.urolonc.2016.07.004_bib23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-2605.2009.01029.x","article-title":"Prospective association of low serum total testosterone levels with health care utilization and costs in a population-based cohort of men","volume":"33","author":"Haring","year":"2010","journal-title":"Int. J Androl"},{"key":"10.1016\/j.urolonc.2016.07.004_bib24","first-page":"232","article-title":"Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate","volume":"22","author":"Huggins","year":"1972","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2016.07.004_bib25","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.juro.2015.05.099","article-title":"Long-term exposure to testosterone therapy and the risk of high-grade prostate cancer","volume":"194","author":"Baillargeon","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.07.004_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bju.12756","article-title":"Testosterone therapy and cancer risk","volume":"115","author":"Eisenberg","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2016.07.004_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.eururo.2013.08.015","article-title":"A new era of testosterone and prostate cancer: from physiology to clinical implications","volume":"65","author":"Khera","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.07.004_bib28","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1007\/s00330-015-3688-1","article-title":"Prostate cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI","volume":"25","author":"H\u00f6tker","year":"2015","journal-title":"Eur Radiol"},{"key":"10.1016\/j.urolonc.2016.07.004_bib29","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/mrm.23062","article-title":"DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: a feasibility study","volume":"67","author":"Barrett","year":"2012","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.urolonc.2016.07.004_bib30","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.2016152542","article-title":"Interobserver reproducibility of the pi-rads version 2 lexicon: a multicenter study of six experienced prostate radiologists","author":"Rosenkrantz","year":"2016","journal-title":"Radiology"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143916301673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143916301673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:08:37Z","timestamp":1761041317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143916301673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1078143916301673"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2016.07.004","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate magnetic resonance imaging findings in patients treated for testosterone deficiency while on active surveillance for low-risk prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2016.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}